Thursday, June 13, 2019

MissionIRNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Subsidiary’s Project Moves to 2nd Phase of Health Canada Review, Approval


VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) on Wednesday announced that its wholly owned subsidiary, ABcann Medicinals Inc., has received notification of the advancement of its Kimmetts project to the second phase of Health Canada’s review and approval process. According to the update, the project is being developed as a hybrid outdoor cultivation site and currently houses four Airstream Innovations(TM) environmental control shelters with cultivation space of 86,000 square feet. “Our airhouses are expected to capitalize on all the benefits and opportunities associated with growing outdoors (low capital and production costs, environmentally sustainable) with the added benefit of mitigating against the known challenges of producing high-quality cannabis outdoors,” said Greg Yuristy, Director of Production for Napanee Operations. “The airhouses are intended to provide protection from the elements and a more consistent cultivation environment, and are expected to result in greater yields and more consistent high quality product than can be produced via outdoor growing. In addition, positive pressure keeps insects and weeds out, eliminating the need for pesticides.”

To view the full press release, visit http://ibn.fm/WuVhS

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology at its Canna Farms facility in Hope, B.C., and at its Vanluven facility in Napanee, Ontario. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), Fireside(TM), Canna Farms(TM) and Lumina(TM). The company is significantly expanding its production capacity and distribution channels; growing its domestic medical cannabis platform, including Harvest Medicine, its patient-centric, highly scalable network of specialty medical cannabis clinics and services; promoting production and cultivation innovation and pursuing partnership and product development opportunities; and actively focusing on growth in select international markets, including Germany and Australia. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html